Detected ·

Neurimmune AG

$425M—

Neurimmune AG, a Swiss biotech, has secured a royalty financing agreement worth up to USD 425 million with Royalty Pharma to accelerate its R&D pipeline, backed by the future commercial potential of cliramitug, an investigational therapy for transthyretin amyloid cardiomyopathy (ATTR-CM) in Phase 3 development.

Amount
$425 000 000 USD
Stage
—
Event
Funding round
Detected
2026-07-23 12:05:13 UTC
Signal ID
2ea7ceb6-89fd-41fd-bc87-1f941fccf359

As the API returns it

{
  "id": "2ea7ceb6-89fd-41fd-bc87-1f941fccf359",
  "created_at": "2026-07-23T12:05:13.223186Z",
  "company_name": "Neurimmune AG",
  "company_website_url": "www.neurimmune.com",
  "company_linkedin_url": "https://www.linkedin.com/company/neurimmune",
  "event_type": "funding",
  "funding_amount": 425000000,
  "funding_currency": "USD",
  "funding_stage": null,
  "message": "*Neurimmune AG, a Swiss biotech, has secured a royalty financing agreement worth up to USD 425 million with Royalty Pharma to accelerate its R&D pipeline, backed by the future commercial potential of cliramitug, an investigational therapy for transthyretin amyloid cardiomyopathy (ATTR-CM) in Phase 3 development.*"
}

Latest rounds

Remedy Robotics$62MOtherLinkedIn
COUNT$6.5MSeedSite / LinkedIn
Nimble Science—AngelSite / LinkedIn
Corma$125MSeries A—
Bedrock Energy$24M—LinkedIn
Corma$125MSeries ALinkedIn
ComeHome—OtherSite / LinkedIn
Queens Court Capital——Site / LinkedIn
FLEXECHARGE——Site / LinkedIn
Numa$45MSeries CLinkedIn
The Vaccine Group (TVG)£500KOtherSite / LinkedIn
AgentWeb—Other—
Corma$125MSeries ALinkedIn
Geminus—Other—
Drogue—Pre-SeedSite / LinkedIn
Traitomic€20M—LinkedIn
Centese——Site / LinkedIn
Accountable$20M—LinkedIn
Zya£12MSeries ASite / LinkedIn
Bedrock Energy$24M—LinkedIn
MediPulse€2.6MPre-SeedSite / LinkedIn
Seawolf Therapeutics$100MSeries A—
CapacityConnect——LinkedIn
Ledgebrook$200M—Site / LinkedIn
Remanence$30MSeedLinkedIn
Hadl.ai——Site / LinkedIn
Noeri$110M——
Accountable$20MSeedLinkedIn
DeteqtA$1.75MOtherSite / LinkedIn
Syntric Medical—Pre-SeedSite / LinkedIn
Watershed Therapeutics——Site / LinkedIn
Index Industries——LinkedIn
Asynchronics$3.1MSeedSite / LinkedIn
Accountable$20MSeedLinkedIn
QB MEN (QB FASHION PVT LTD)—Pre-SeedSite / LinkedIn
Remanence$30MPre-SeedSite / LinkedIn
Dodai$3MSeries ASite / LinkedIn
Accountable$20MSeedLinkedIn
Traitomic€20MSeries ASite / LinkedIn
Trajectory$45MSeries A—
Noeri$110M—LinkedIn
Commit Biologics$60MSeedSite / LinkedIn
Genesis Space Flight Laboratories€1.2M——
Fermat$8M—LinkedIn
Cardiff Canning£550KOtherSite / LinkedIn
Stark Future SL€150MOtherLinkedIn
Well€3.6MPre-SeedSite / LinkedIn
Knit Health$35MSeries ALinkedIn
Azoma$11.2MSeries ASite / LinkedIn
Qluster€4.7MPre-SeedSite / LinkedIn